Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIDCR

INTEGRIN CD18 IS A NOVEL STROMAL STEM CELL MARKER AND FUNCTIONS TO PROMOTE OSTEOGENESIS

  • Read more about INTEGRIN CD18 IS A NOVEL STROMAL STEM CELL MARKER AND FUNCTIONS TO PROMOTE OSTEOGENESIS
US Application 60/606,982
Filed on 2004-09-06

Long-acting Ophthalmic Analgesic Eye Drops

  • Read more about Long-acting Ophthalmic Analgesic Eye Drops
US Application 61/247,881
Filed on 2009-10-01

Prevention And Treatment Of Oral And Lips Diseases Using Sirolimus And Derivatives Sustained Release Delivery Systems For Local Application To The Oral Cavity

  • Read more about Prevention And Treatment Of Oral And Lips Diseases Using Sirolimus And Derivatives Sustained Release Delivery Systems For Local Application To The Oral Cavity
US Application 61/237,062
Filed on 2009-08-26

Sensitive And Robust Luminescent Detection Of Anti-La-SSB Auto-antibodies

  • Read more about Sensitive And Robust Luminescent Detection Of Anti-La-SSB Auto-antibodies
US Application 61/224,649
Filed on 2009-07-10

Use Of A Hybrid Adenoretroviral Vector To Prevent Radiation-induced Oral Mucositis Following Gene Transfer To Salivary Glands

  • Read more about Use Of A Hybrid Adenoretroviral Vector To Prevent Radiation-induced Oral Mucositis Following Gene Transfer To Salivary Glands
US Application 61/176,210
Filed on 2009-05-07

Compound Deletions Of TGF-beta Receptor I And Pten Genes Cause Head And Neck Squamous Cell Carcinoma

  • Read more about Compound Deletions Of TGF-beta Receptor I And Pten Genes Cause Head And Neck Squamous Cell Carcinoma
US Application 61/176,723
Filed on 2009-05-08

Identification Of DSG3 As A Biomarker For The Detection Of Metastasis In Lymph Nodes

  • Read more about Identification Of DSG3 As A Biomarker For The Detection Of Metastasis In Lymph Nodes
US Application 61/186,582
Filed on 2009-06-12

Differentially Expressed MicroRNAs as Biomarkers for the Diagnosis and Treatment of Sjogren's

  • Read more about Differentially Expressed MicroRNAs as Biomarkers for the Diagnosis and Treatment of Sjogren's
US Application 61/165,142
Filed on 2009-03-31

Serological Screening For HHV-8 Infection Using Antigen Mixtures

  • Read more about Serological Screening For HHV-8 Infection Using Antigen Mixtures
US Application 61/152,058
Filed on 2009-02-12

Cell-based Assay To Screen Regulators Of Cyclin-dependent Kinase 5 (Cdk5/P35) Kinase Activity08

  • Read more about Cell-based Assay To Screen Regulators Of Cyclin-dependent Kinase 5 (Cdk5/P35) Kinase Activity08
US Application 61/198,246
Filed on 2008-11-03

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIDCR
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health